Henry Meds
The full profile retains its earlier verification date. Check the dated program terms below before choosing.
Edited by Designing Longevity Editorial · earlier profile checked May 1, 2026
2.7
of 5 · earlier editorial rating
May 1, 2026
The editorial rating reflects checks from May 1, 2026. Program terms below have separate source dates. Neither is a medical or pharmacy inspection.
No financial relationship with Henry Meds. Editorial inclusion only.
Program costs and payment terms
Current program terms need a fresh check. Get a written price and billing quote directly before paying.
- Membership
- Current membership price needs a fresh check.
- Insurance
- Insurance terms need a fresh check; confirm directly before paying.
Designing Longevity is a founder-led editorial publication. Our content is not medically reviewed.
The full profile and rubric were last checked May 1, 2026. Current commercial terms above have their own check date; they do not refresh earlier ratings or clinical claims.
Earlier editorial take
Look elsewhere if
Users who want a clean per-fill sourcing chain
Specific compounding-pharmacy partners are not publicly named at fill level, and there is no published lot-testing program. Eden's vertically-integrated model is meaningfully more transparent.
Our take
The full profile retains its earlier verification date. Check the dated program terms below before choosing.
Pros
- Both oral and injectable options for semaglutide and tirzepatide
- No FDA warning letter on Henry Meds or Adonis Health (verified vs Sept 2025 and March 2026 enforcement rounds)
- Operating entity (Adonis Health, Inc.) is verifiable via federal court filings
Cons
- BBB F rating, NOT accredited; 192 complaints in three years with 25 unanswered
- Trustpilot 4.5/5 average is undercut by a suspected-fraudulent-review notice on the profile page
- Active Eli Lilly lawsuit (4:25-cv-03536) over compounded tirzepatide marketing; personalization claim survived dismissal
- Phone-only cancellation, no self-serve in-app flow; multiple complaints describe unanswered calls
- LegitScript certification not independently confirmable on a public registry
Pricing
Current pricing needs a fresh check.
Turnaround
Same-day Rx after async intake
States served
All 50
Earlier full review checked
May 1, 2026
Earlier rubric breakdown
How the earlier rating was scoredLicensure
20% weightLicense and enforcement records checked at the profile verification date.
No FDA warning letter on Henry Meds or Adonis Health, verified against the FDA warning-letter database at capture date and against the March 3, 2026 batch of 30 telehealth warning letters (Henry Meds was not on that list). Counterweight: an active Eli Lilly lawsuit (4:25-cv-03536, N.D. Cal., filed April 23, 2025) survived a partial motion-to-dismiss order on September 24, 2025, with the personalization-marketing claim allowed to proceed. The case is marketing/false-advertising, not product safety, but it is ongoing legal pressure rather than a closed chapter.
Evidence checked in the earlier review (4)
Adonis Health, Inc. d/b/a Henry Meds (operating entity)
Business filingConfirmed via the docket caption in Eli Lilly and Company v. Adonis Health, Inc., 4:25-cv-03536, Northern District of California.
Checked May 1, 2026 · source
No FDA warning letter on Henry Meds / Adonis Health
Federal databaseVerified against the FDA warning-letter database. Specifically not named in either the September 2025 round of warning letters to GLP-1 telehealth companies or the March 3, 2026 batch of 30 letters. Several cohort competitors (Hims, MEDVi, Direct Meds) were in the September 2025 round; Henry Meds was not.
Checked May 1, 2026 · source
Eli Lilly v. Adonis Health (Henry Meds) active lawsuit
Civil litigationEli Lilly filed in April 2025 alleging deceptive marketing of compounded tirzepatide as 'personalized' and as equivalent to FDA-approved Mounjaro/Zepbound. Sept 24, 2025 order from Judge Jon S. Tigar granted in part and denied in part Henry Meds's motion to dismiss; the personalization-marketing claim survived. Case remains active.
Checked May 1, 2026 · source
Active state pharmacy / clinic licensure
State licensureHenry Meds operates across all 50 states via licensed independent prescribers.
Checked May 1, 2026
Accreditation
20% weightAccreditation records checked at the profile verification date.
The weakest accreditation posture in our cohort. Henry Meds is NOT BBB-accredited, with an F letter grade and 192 complaints filed over the last three years (25 of which received no response from the business). LegitScript certification is unconfirmed on a public registry. There are no compensating accreditations to offset the BBB picture.
Evidence checked in the earlier review (2)
LegitScript Healthcare Merchant Certification
AccreditationNot independently verifiable on a public registry. Henry Meds advertises on Google and Meta, which generally requires LegitScript certification (Google's pharmacy advertising policy requires it for telehealth merchants), so it is a reasonable inference, but we cannot confirm against a public source the way we can confirm a BBB profile.
Checked May 1, 2026 · source
PCAB on partner compounding pharmacies
Partner accreditationSpecific compounding-pharmacy partners and their accreditation status are not publicly disclosed at the per-fill level.
Checked May 1, 2026
Transparency
20% weightPublished testing, sourcing, and formulation information.
That structure is the most common complaint theme.
Evidence checked in the earlier review (1)
Compounded sourcing disclosure (compounded ≠ FDA-approved)
Compliance disclosureHenry Meds publishes the standard compounded-not-FDA-approved disclaimer.
Checked May 1, 2026
Product quality
15% weightPublished testing, recall, and supply-chain information.
This earlier product-quality score has not been refreshed. The commercial update does not recheck manufacturing, sourcing or clinical care.
Evidence checked in the earlier review (4)
No FDA recalls on Henry Meds-distributed product
Recall historyChecked May 1, 2026 · source
Lawsuit scope: marketing, not safety
Litigation scopeThe Eli Lilly case alleges deceptive marketing of 'personalized' compounded tirzepatide, not unsafe or contaminated product. Important distinction when weighing product-quality risk.
Checked May 1, 2026
Compounding partner identity at fill level
SourcingSpecific 503A or 503B compounding partner per fill is not surfaced publicly. Less transparent than vertically-integrated competitors like Eden.
Checked May 1, 2026
Third-party lot testing program
TestingNo publicly-detailed lot-by-lot testing program of the kind some competitors publish.
Checked May 1, 2026
Pricing
15% weightValue within the category, no surprise fees, refund policy.
Current pricing needs a fresh check.
Customer service
10% weightRefund policy, support quality, complaint history.
The cohort's worst customer-service signal stack. BBB shows F rating with 192 complaints in three years, 25 of which received no business response. Honest framing: do not trust the Trustpilot headline number alone.
Evidence checked in the earlier review (3)
BBB F rating with 192 complaints / 25 unanswered
Complaint historyF is the lowest BBB grade. Twenty-five unanswered complaints is the responsiveness signal that drove the F.
Checked May 1, 2026 · source
Trustpilot 4.5/5 across ~12,300 reviews, flagged for suspected fake reviews
External reviewThe 4.5-star headline is real, but Trustpilot itself displays a suspected-fraudulent-review notice on the page, which undercuts the credibility of the score. We are weighing the notice as more meaningful than the average.
Checked May 1, 2026 · source
Async-only consultations, no labs before prescribing
Care modelStandard for the cohort, but worth noting alongside the broader concerns.
Checked May 1, 2026
Public reviews
What we found across third-party review platforms. These are external sentiment signals, not our scoring inputs.
Trustpilot
4.5/5 across roughly 12,300 reviews on the surface, but the Trustpilot profile itself carries a suspected-fraudulent-review notice. We weight the notice heavily: the headline number does not mean what it appears to mean. Genuine positive themes still exist (convenience, fast shipping); negative themes match BBB (cancellation friction, surprise charges).
Better Business Bureau
F rating, NOT accredited. 192 complaints in three years; 25 received no business response. Complaint themes cluster on auto-renewal billing without delivery, a secondary $49/month subscription buried in terms of service, and cancellation resistance. The non-response rate is itself a signal.
ConsumerAffairs
Recurring negative themes match BBB: charged after cancellation, no medication delivered, no refund. Pattern matches enough that we treat it as a real signal across platforms rather than a single-platform anomaly.
Regulatory & legal history
FDA enforcement actions, manufacturer lawsuits, recalls, and other notable events on the public record.
- Lawsuit FiledApril 23, 2025
Eli Lilly and Company filed Eli Lilly v. Adonis Health, Inc. d/b/a Henry Meds (Case 4:25-cv-03536) in the U.S. District Court for the Northern District of California, alleging deceptive marketing of compounded oral tirzepatide as 'personalized' and as equivalent to FDA-approved Mounjaro and Zepbound. Lanham Act and California consumer-protection claims.
Source - Lawsuit FiledSeptember 24, 2025
Judge Jon S. Tigar issued an order granting in part and denying in part Henry Meds's motion to dismiss. Personalization-marketing claim was allowed to proceed; a separate 'safe and effective' marketing claim was dismissed. Eli Lilly was given until October 15, 2025 to file an amended complaint. Case remains active as of capture date.
Source
What to expect
- 1
Async intake form
10-15 minOnline intake covering current weight, BMI, medical history, and weight-loss goals. No labs ordered before prescribing (cohort-typical for compounded GLP-1 telehealth).
- 2
Clinician review
Same dayLicensed clinician reviews the intake and issues a prescription if appropriate. Same-day Rx is the typical outcome.
- 3
Compounding pharmacy fulfillment
3-7 daysApproved Rx routes to a partner compounding pharmacy. Cold-chain shipping for injectables; tablets ship standard. Specific partner per fill is not publicly disclosed.
Accreditations
State pharmacy/clinic license
Verified · May 1, 2026
LegitScript Certified
Unverified · May 1, 2026 · source
Frequently asked
What does Henry Meds charge for membership?
Current membership price needs a fresh check.
Does Henry Meds accept insurance?
Insurance terms need a fresh check; confirm directly before paying.
What is the Eli Lilly lawsuit against Henry Meds?
Eli Lilly and Company v. Adonis Health, Inc. d/b/a Henry Meds (Case 4:25-cv-03536) was filed April 23, 2025 in the U.S. District Court for the Northern District of California. Lilly alleges Henry Meds deceptively markets compounded tirzepatide as 'personalized' and as equivalent to Lilly's FDA-approved Mounjaro and Zepbound. On September 24, 2025, Judge Jon S. Tigar granted in part and denied in part Henry Meds's motion to dismiss; the personalization-marketing claim survived. The case is about marketing language, not product safety, but it is active litigation rather than a closed chapter.
Update history
Every meaningful change to this profile, with a date stamp. We don't silently re-score.
- May 1, 2026
Initial published profile. Sources HEAD-checked at publish time. Score (2.7) reflects the cohort-cheapest pricing weighted against the cohort-worst trust posture: BBB F with 25 unanswered complaints, Trustpilot suspected-fraudulent-review notice, and active Eli Lilly v. Adonis Health (4:25-cv-03536) over compounded-tirzepatide marketing. Honest framing: list Henry Meds because the price gap is real, but route most readers to TrimRx or Eden for trust posture.
Compare Henry Meds head-to-head
Compare dated terms, public records and the questions still needing verification.
vs Eden
Compare Eden and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonvs TrimRx
Compare Henry Meds and TrimRx using dated program terms and clearly labeled evidence limits.
Read comparisonvs Mochi Health
Compare Mochi Health and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonvs Ro
Compare Ro and Henry Meds using dated program terms and clearly labeled evidence limits.
Read comparisonEdited by Designing Longevity Editorial. Earlier profile checked May 1, 2026.
Spot something out of date or wrong? Let us know and we'll re-check.
Back to all providers